Patients in the MRC Myeloma XI trial receiving induction chemotherapy for newly diagnosed multiple myeloma containing dexamethasone at full or moderated dose have significantly reduced half-life of IgG

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Giles HV, Cook M, Richter A, Ferretti L, Kaiser M, Davies FE, Gregory WM, Owen RG, Jackson GH, Child JA, Morgan GJ, Drayson MT

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: XXXVI World Congress of the International Society of Hematology

Year of Conference: 2016

Pages: 107-108

Print publication date: 01/04/2016

Online publication date: 12/04/2016

Acceptance date: 02/04/2016

ISSN: 0963-1860

Publisher: Wiley-Blackwell

URL: http://dx.doi.org/10.1111/bjh.14019

DOI: 10.1111/bjh.14019

Series Title: British Journal of Haematology

ePrints